Cheryl Gault
Chief Operating Officer presso Rapport Therapeutics, Inc.
Patrimonio netto: 2 646 $ in data 31/03/2024
Profilo
Cheryl Gault is currently the Chief Operating Officer at Rapport Therapeutics, Inc. Her former jobs include being the Head of Sales & Marketing at Genzyme Corp., and the VP of Commercial Strategy & New Product Planning at Ironwood Pharmaceuticals, Inc. from 2017 to 2019.
She was also the Chief Operating Officer at Cyclerion Therapeutics, Inc. from 2021 to 2023.
Ms. Gault received her undergraduate degree from Boston College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 15/06/2023 | 827 ( 0.03% ) | 2 646 $ | 31/03/2024 |
Posizioni attive di Cheryl Gault
| Società | Posizione | Inizio |
|---|---|---|
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | Chief Operating Officer | 07/09/2023 |
Precedenti posizioni note di Cheryl Gault
| Società | Posizione | Fine |
|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Chief Operating Officer | 28/07/2023 |
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2019 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Sales & Marketing | - |
Formazione di Cheryl Gault
| Boston College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| CYCLERION THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | Health Technology |
- Borsa valori
- Insiders
- Cheryl Gault
